935.50
1,511.00
1,189
1,229.50
1,220.15
1,220.15
17.59%
-9.42%
32,184.83
2,64,334
Is the price-earnings ratio for valuing a company that measures its current share price relative to its earnings per share.
The earnings per share ratio is a portion of company's net profit allocated for each outstanding share. It is calculated by deducting preferred stock divided from the net income of the company divided by the number of outstanding shares.
Price-to-book ratio is used to compared the company's current market price with its book value.
These are the acutal number of shares that are traded on delivery based, meaning transfered from one person to another during the day's trade.
Dividend Yield measures the quantum of cash dividends paid to shareholders in a financial year relative to the market value of the per share.
Company Details
Check out the key parameters of the company to understand the financial health and stock performance
-
Technical
The key levels help you plan your entry and exit point.
-
PROFIT & LOSS
Take a quick look at the revenues and expenditure sheet.
-
Balance Sheet
Its a statement of assets, liabilities and share capital.
-
Dividend History
Check out the detailed payout data over the last three years.
-
Comparative Returns
Reveals how the stock has fared compared to the BSE, NSE benchmark indices.
Key Level
1248.07
1275.98
1204.12
1188.08
Moving Average
1211.08
1142.80
1118.69
1130.18
Growth in 3 years
29.18%
Sales Industry Avg
4.63%
PAT
64.96%
PAT Industry Avg
6.30%
Dec 2024 ( in Cr.) | Sep 2024 ( in Cr.) | Jun 2024 ( in Cr.) | Mar 2024 ( in Cr.) | FY 2024 ( in Cr.) | |
---|---|---|---|---|---|
Sales | 943.44 | 956.56 | 861.08 | 808.63 | 2,280.01 |
Gross Profit | 237.51 | 230.53 | 190.27 | 188.54 | 575.76 |
Operating Profit | 0 | 0 | 0 | 0 | 0 |
Profit Before Tax | 182.52 | 179.43 | 142.68 | 166.55 | 488.67 |
Tax | 39.66 | 48.61 | 36.42 | 39.20 | 127.78 |
Profit After Tax | 142.86 | 130.82 | 106.26 | 127.35 | 360.89 |
Growth in 3 years
53.11%
Total Liabilities growth
53.44%
Reserves Change
78.17%
Mar 2023 ( in Cr.) | Mar 2022 ( in Cr.) | Mar 2021 ( in Cr.) | Mar 2020 ( in Cr.) | Mar 2019 ( in Cr.) | |
---|---|---|---|---|---|
Share Capital | 53.64 | 50.64 | 49.59 | 49.35 | 49.13 |
Reserves And Surplus | 2,374.57 | 1,565.36 | 1,332.76 | 1,300.19 | 1,246.36 |
Investments | 0.05 | 0.05 | 0.05 | 0 | 0 |
Total Debt | 1,121.95 | 1,108.93 | 931.38 | 928.91 | 786.94 |
Total Liabilities | 3,550.16 | 2,724.93 | 2,313.73 | 2,278.45 | 2,082.43 |
Total Assets | 3,530.30 | 2,740.79 | 2,305.70 | 2,250.76 | 2,065.75 |
458.70%
Relative to Nifty rtn in 3 year
419.86%
Relative to top 3 MF rtn in 3 year
1 Year (%) | 2 Year (%) | 3 Year (%) | |
---|---|---|---|
Global Health | -9 | 156 | 192 |
Bse Sensex | 6 | 34 | 34 |
Nifty 50 | 7 | 39 | 37 |
Nifty 500 | 7 | 50 | 46 |
Peer Companies
A quick glance on how stocks from the same sector have performed along with some key parameters
1213.85 chg : -6.30 (-0.52%)
1129.40 chg : 6.85 (0.61%)
6492.05 chg : -27.75 (-0.43%)
671.80 chg : 26.10 (4.04%)
1673.40 chg : 43.55 (2.67%)
Return Calculator
This tools helps you project your potential return on investments for the given stock, for a specified amount over a per-defined period of time.
Our Research Reports
Stocks and sector-wise Research Reports by HDFC securities help you analyse, understand and take a informed investment decision.
Report
Corporate Action
Find out the historical dividend payout and other corporate actions including bonus, stock split and rights issue etc.
Our Research Analysis
__PERCENT__%
Target Achived
Potential Upside
__TARGETRETURN__%
Buy Call with __TIMEFRAME__ time frame
__Rationale__
__DATE__
__MONTHYEAR__ |
Call initiated Target: __TARGET__ |
Target Gain __TG__ % | Reco Price: __RP__ | Stop loss: __SL__ | HORIZON : __HORIZN__ |
FnO
A snapshot on how the stock has performed in the derivatives segment on a real-time basis.
No data available |
MF Holdings
Here's a list of major funds which hold the stock in their portfolio as of the last reported quarter.
Scheme Name | AUM (%) | CMV ( in Cr.) | Holding Date |
---|---|---|---|
No data available |
News
Stay tuned to the latest developments and happenings in the company.
Global Health receives affirmation in credit ratings from CRISIL
Global Health has received affirmation in credit ratings from CRISIL Ratings pursuant to merger of Medanta Holdings (MHPL), erstwhile wholly owned sub....
18 Mar 2025 19:30Global Health receives affirmation in credit ratings for bank facilities
Global Health has received reaffirmation in credit rating for bank facilities of Rs 950 crore at CRISIL AA-; Positive/ CRISIL A1 . Powered by....
05 Feb 2025 14:15Global Health consolidated net profit rises 15.59% in the December 2024 quarter
Net profit of Global Health rose 15.59% to Rs 142.91 crore in the quarter ended December 2024 as against Rs 123.64 crore during the previous quarter e....
04 Feb 2025 17:24Global Health to announce Quarterly Result
Global Health will hold a meeting of the Board of Directors of the Company on 4 February 2025.Powered by Capital Market - Live News</....
22 Jan 2025 10:17Global Health consolidated net profit rises 4.54% in the September 2024 quarter
Net profit of Global Health rose 4.54% to Rs 130.84 crore in the quarter ended September 2024 as against Rs 125.16 crore during the previous quarter e....
14 Nov 2024 15:15Global Health consolidated net profit rises 4.20% in the June 2024 quarter
Net profit of Global Health rose 4.20% to Rs 106.29 crore in the quarter ended June 2024 as against Rs 102.01 crore during the previous quarter ended ....
08 Aug 2024 17:34__heading__
Published on __date__ at __time__
__description__